InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,427.13
(
-2.31%
)
US TECH 100
18,598.80
(
-3.26%
)
Dow Jones
39,853.87
(
-1.25%
)
Brent Oil
80.74
(
-0.05%
)
Bitcoin
65,313.17
(
-0.92%
)
Post# of 252666
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 120111
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: justrpaul post# 200283

Monday, 10/19/2020 7:28:17 PM

Monday, October 19, 2020 7:28:17 PM

Post# of 252666
CBLI—(+41%/AH)—reverse-merges into Cytocom Inc:

https://finance.yahoo.com/news/cytocom-cleveland-biolabs-announce-definitive-200500691.html

Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis… Specifically, Cytocom has four programs in late-stage clinical development in Crohn's disease, Fibromyalgia, Multiple Sclerosis and Pancreatic Cancer.

The PR doesn’t say what the equity split will be, but it does say that Cytocom shareholders will end up with a majority stake.

CC Tuesday at 8am ET.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up